Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation.
about
Pompe disease: Shared and unshared features of lysosomal storage disordersModulation of mTOR signaling as a strategy for the treatment of Pompe disease.A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS CellsL-leucine and SPNS1 coordinately ameliorate dysfunction of autophagy in mouse and human Niemann-Pick type C disease.
P2860
Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@ast
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@en
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@nl
type
label
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@ast
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@en
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@nl
prefLabel
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@ast
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@en
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@nl
P2093
P2860
P1476
Suppression of mTORC1 activati ...... ed by leucine supplementation.
@en
P2093
Adi Shemesh
Danielle E Johnson
Gong-She Yang
Haihong Zong
Jeffrey E Pessin
Jonathan M Backer
Yichen Wang
Yingjuan Yang
P2860
P304
P356
10.1152/AJPREGU.00212.2014
P577
2014-09-17T00:00:00Z